We suggest that while IR in critically ill patients is a consequence of systemic inflammation mediated by TNF-α per se, the impaired incretin effect is not directly related to inflammation; it more likely occurs secondary to the development of hyperglycaemia. This evidence concerns the gene TNF and Hyperglycemia.